Biomacromolecules,
Journal Year:
2024,
Volume and Issue:
25(4), P. 2563 - 2573
Published: March 14, 2024
In
the
current
years,
polydopamine
nanoparticles
(PDA
NPs)
have
been
extensively
investigated
as
an
eumelanin
mimic.
However,
unlike
natural
eumelanin,
PDA
NPs
contain
no
5,6-dihydroxyindole-2-carboxylic
acid
(DHICA)-derived
units
and
may
be
limited
in
certain
intrinsic
properties;
superior
eumelanin-like
nanomaterials
are
still
actively
being
sought.
Levodopa
(l-DOPA)
is
a
precursor
expected
to
convert
into
DHICA
further
remain
within
final
product
through
covalent
or
physical
interactions.
Herein,
poly(levodopa)
[P(l-DOPA)
NPs]
were
synthesized
with
assistance
of
zinc
oxide
supplement
synthetic
eumelanin.
This
study
found
that
P(l-DOPA)
had
∼90%
DHICA-derived
subunits
on
their
surface
exhibited
antioxidant
activity
compared
due
looser
polymeric
microstructure.
Benefitting
from
stronger
ROS
scavenging
ability,
outperformed
treating
cellular
oxidative
stress
acute
inflammation.
research
opens
up
new
possibilities
for
development
application
novel
melanin-like
materials.
Materials Today Bio,
Journal Year:
2025,
Volume and Issue:
30, P. 101445 - 101445
Published: Jan. 5, 2025
Chemotherapy
is
widely
recognized
as
a
highly
efficacious
modality
for
cancer
treatment,
involving
the
administration
of
chemotherapeutic
agents
to
target
and
eradicate
tumor
cells.
Currently,
oral
stands
prevailing
utilized
method
delivering
chemotherapy
drugs.
However,
majority
anti-tumor
medications
exhibit
limited
solubility
permeability,
poor
stability
in
harsh
gastrointestinal
environments,
thereby
impeding
their
therapeutic
efficacy
chemotherapy.
Therefore,
more
micro-nano
drug
delivery
carriers
have
been
developed
used
effectively
deliver
anti-cancer
drugs,
which
can
overcome
physiological
barriers,
facilitate
administration,
ultimately
improve
efficacy.
In
this
paper,
we
first
discuss
effects
various
biological
barriers
on
approach.
Then,
development
based
biomedical
components,
such
micelles,
dendrimers,
hydrogels,
liposomes,
inorganic
nanoparticles,
etc.
were
introduced.
Finally,
current
dilemma
potential
clinical
treatment
discussed.
The
primary
objective
review
introduce
methods
serve
point
reference
advancement
novel
carriers,
with
ultimate
goal
informing
future
applications.